2026 Updates in Cancer Therapies | Early-stage Hormone Receptor Positive Breast Cancer: Targeting Therapy to Risk Balanced with Toxicity

2026 Updates in Cancer Therapies | Early-stage Hormone Receptor Positive Breast Cancer: Targeting Therapy to Risk Balanced with Toxicity

0% Complete

Course Content

Credits

  • AMA PRA Category 1 Creditâ„¢Non-CME

Course Details

Duration
0.00 hour
Released
Jan 17, 2026
Last Review
Jan 17, 2026
Expires
Jan 17, 2027

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

Faculty & Disclosure

Faculty

Delia Constanza Guaqueta, MD

Accreditation

NA